日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The plasma nanoDSF denaturation profiles predict the presence of breast cancer

等离子体纳米差示扫描量热法(nanoDSF)变性曲线可预测乳腺癌的存在

Guerin, Mathilde; Eyraud, Rémi; Tsvetkov, Philippe; Finetti, Pascal; Giraudo, Alexandre; Tarpin, Carole; Hassin, Aymen; Bechlian, Didier; Mamessier, Emilie; Pakradouni, Jihane; Boher, Jean-Marie; Goncalves, Anthony; Devred, François; Bertucci, François

A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing

针对全外显子组测序,对单个体细胞变异检测器和基于投票的集成检测器进行基准测试研究

Guille, Arnaud; Adélaïde, José; Finetti, Pascal; Andre, Fabrice; Birnbaum, Daniel; Mamessier, Emilie; Bertucci, François; Chaffanet, Max

Mutational landscape of inflammatory breast cancer

炎症性乳腺癌的突变图谱

Bertucci, François; Lerebours, Florence; Ceccarelli, Michele; Guille, Arnaud; Syed, Najeeb; Finetti, Pascal; Adélaïde, José; Van Laere, Steven; Goncalves, Anthony; Viens, Patrice; Birnbaum, Daniel; Mamessier, Emilie; Callens, Céline; Bedognetti, Davide

Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy

炎性乳腺癌的全外显子组谱及新辅助化疗的病理反应

Bertucci, François; Guille, Arnaud; Lerebours, Florence; Ceccarelli, Michele; Syed, Najeeb; Adélaïde, José; Finetti, Pascal; Ueno, Naoto T; Van Laere, Steven; Viens, Patrice; De Nonneville, Alexandre; Goncalves, Anthony; Birnbaum, Daniel; Callens, Céline; Bedognetti, Davide; Mamessier, Emilie

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer

放射性药物镭-223对患者具有免疫调节作用,并能促进骨转移性前列腺癌小鼠模型中抗程序性死亡受体-1疗法的疗效。

Saylor, Philip J; Kozin, Sergey V; Matsui, Aya; Goldberg, Saveli I; Aoki, Shuichi; Shigeta, Kohei; Mamessier, Emilie; Smith, Matthew R; Michaelson, M Dror; Lee, Richard J; Duda, Dan G

Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies

解读卵巢癌中叶酸受体α基因表达和mRNA特征:对精准治疗的启示

Kfoury, Maria; Finetti, Pascal; Mamessier, Emilie; Bertucci, François; Sabatier, Renaud

Endometrioid ovarian carcinoma landscape: pathological and molecular characterization

子宫内膜样卵巢癌概况:病理学和分子特征

de Nonneville, Alexandre; Kalbacher, Elsa; Cannone, Francesco; Guille, Arnaud; Adelaïde, José; Finetti, Pascal; Cappiello, Maria; Lambaudie, Eric; Ettore, Giuseppe; Charafe, Emmanuelle; Mamessier, Emilie; Provansal, Magali; Bertucci, François; Sabatier, Renaud

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer

三级淋巴结构特征对HER2阴性乳腺癌新辅助化疗反应和免疫治疗获益的预测能力

Bertucci, François; De Nonneville, Alexandre; Finetti, Pascal; Mamessier, Emilie

The MonarchE trial: improving the clinical outcome in HR(+) /HER2(-) early breast cancer: recent results and next steps

MonarchE试验:改善HR(+)/HER2(-)早期乳腺癌的临床结局:最新结果和后续步骤

Bertucci, François; Finetti, Pascal; Mamessier, Emilie; De Nonneville, Alexandre

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

免疫排斥常数作为非小细胞肺癌免疫检查点抑制剂疗效的预测性生物标志物

Mogenet, Alice; Finetti, Pascal; Denicolai, Emilie; Greillier, Laurent; Boudou-Rouquette, Pascaline; Goldwasser, François; Lumet, Gwenael; Ceccarelli, Michele; Birnbaum, Daniel; Bedognetti, Davide; Mamessier, Emilie; Barlesi, Fabrice; Bertucci, François; Tomasini, Pascale